Pharmacogenomics of Aromatase Inhibitor Associated Arthralgia: Personalized Medicine for Patients with ER plus Breast Cancer

被引：0
|
作者：
Borrie, Adrienne [1 ]
Teft, Wendy [1 ]
Kim, Richard [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2017年 / 88卷
关键词：
D O I：
10.1016/j.vascn.2017.09.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
0006
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [31] AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
    Rechoum, Yassine
    Rovito, Daniela
    Iacopetta, Domenico
    Barone, Ines
    Ando, Sebastiano
    Weigel, Nancy L.
    O'Malley, Bert W.
    Brown, Powel H.
    Fuqua, Suzanne A. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (03) : 473 - 485
  • [32] Arthralgia Occurring Under Aromatase Inhibitor Treatment For Breast Cancer. A Prospective Study.
    Wendling, Daniel
    Letho-Gyselinck, Helene
    Guillot, Xavier
    Prati, Clement
    Pivot, Xavier
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S874 - S874
  • [33] Feasibility trial of electro-acupuncture for aromatase inhibitor related arthralgia in breast cancer survivors
    Mao, J. J.
    Stricker, C. T.
    Farrar, T.
    Xie, S. X.
    Bowman, M. A.
    Bruner, D. W.
    Pucci, D.
    Han, X.
    DeMichele, A.
    CANCER RESEARCH, 2009, 69 (02) : 233S - 233S
  • [34] Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER plus breast cancer in postmenopausal patients
    Gao, Qiong
    Lopez-Knowles, Elena
    Cheang, Maggie Chon U.
    Morden, James
    Ribas, Ricardo
    Sidhu, Kally
    Evans, David
    Martins, Vera
    Dodson, Andrew
    Skene, Anthony
    Holcombe, Chris
    Mallon, Elizabeth
    Evans, Abigail
    Bliss, Judith M.
    Robertson, John
    Smith, Ian
    Martin, Lesley-Ann
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2019, 22 (01)
  • [35] A RANDOMIZED TRIAL OF ELECTROACUPUNCTURE FOR FATIGUE, SLEEP, AND PSYCHOLOGICAL DISTRESS IN BREAST CANCER PATIENTS WITH AROMATASE INHIBITOR-RELATED ARTHRALGIA
    Jun Mao
    Journal of Integrative Medicine, 2014, (03) : 296 - 297
  • [36] ARTHRALGIA OCCURRING UNDER AROMATASE INHIBITOR TREATMENT FOR BREAST CANCER. A PROSPECTIVE CONTROLLED STUDY
    Wendling, D.
    Letho-Gyselinck, H.
    Guillot, X.
    Prati, C.
    Pivot, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 722 - 722
  • [37] Final results of the randomized trial of exercise intervention vs. usual care for breast cancer patients with aromatase inhibitor to prevent and improve the aromatase inhibitor induced arthralgia
    Tamaki, Kentaro
    Takaesu, Mustuyo
    Nagamine, Sayaka
    Terukina, Shigeharu
    Kamada, Yoshihiko
    Uehara, Kano
    Takigami, Naoko
    Arakaki, Miwa
    Yamashiro, Kazuko
    Miyashita, Minoru
    Ishida, Takanori
    McNamara, Keely May
    Tamaki, Nobumitsu
    Sasano, Hironobu
    CANCER RESEARCH, 2018, 78 (04)
  • [38] Electroacupuncture for Fatigue, Sleep, and Psychological Distress in Breast Cancer Patients With Aromatase Inhibitor-Related Arthralgia: A Randomized Trial
    Mao, Jun J.
    Farrar, John T.
    Bruner, Deborah
    Zee, Jarcy
    Bowman, Marjorie
    Seluzicki, Christina
    DeMichele, Angela
    Xie, Sharon X.
    CANCER, 2014, 120 (23) : 3744 - 3751
  • [39] GENES ASSOCIATED WITH PLASMA ANASTROZOLE, AN AROMATASE INHIBITOR, AND HYDROXYANASTROZOLE GLUCORONIDE CONCENTRATIONS IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE (ER plus ) BREAST CANCER
    Dudenkov, Tanda M.
    Ingle, James N.
    Kalari, Krishna R.
    Desta, Zeruesenay
    Buzdar, Aman U.
    Robson, Mark E.
    Goetz, Matthew P.
    Northfelt, Donald W.
    Perez, Edith A.
    Kubo, Michiaki
    Wang, Liewei
    Weinshilboum, Richard
    DRUG METABOLISM REVIEWS, 2015, 47 : 213 - 214
  • [40] Factors associated with aromatase inhibitor associated musculoskeletal symptoms in early stage breast cancer patients
    Sun, Yamin
    Elder, Simran
    Jung, Seungyoun
    Mainor, Candace
    Murali, Shruti
    Rosenblatt, Paula
    Tkaczuk, Katherine
    CANCER RESEARCH, 2020, 80 (04)
12345